Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

NERV US Equity

Minerva Neurosciences, Inc.Health Care · Pharmaceutical Preparations · CIK 1598646 · FY ends Dec 31
$4.79
+0.25 (+5.51%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BALYASNY ASSET MANAGEMENT L.P.sec.gov ↗
2026-08-1313G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FARALLON CAPITAL MANAGEMENT, L.L.C.sec.gov ↗
2026-08-128-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-08-078-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-0813G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FEDERATED HERMES, INC.sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-08

Every row is a filed document, checked against its EDGAR index.